<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Faizy TD</submitter><funding>NINR NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Current randomized controlled trials are investigating the efficacy and safety of mechanical thrombectomy (MT) in patients with medium vessel occlusion (MeVO) stroke. Whether best medical management (MM) is more efficient than unsuccessful vessel recanalization during MT remains unknown.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study using data from 37 academic centers across North America, Asia, and Europe between September 2017 and July 2021. Only patients with occlusion of the distal branches (M2 and M3) of the middle cerebral artery territory were included. Unsuccessful MT was defined as a modified Thrombolysis in Cerebral Infarction score of 0-2a. Propensity score matching was used to control for confounders. The primary outcome was functional independence, de</pubmed_abstract><journal>Journal of neurointerventional surgery</journal><pagination>jnis-2024-022642</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12284089</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical outcomes of patients with unsuccessful mechanical thrombectomy versus best medical management of medium vessel occlusion stroke in the middle cerebral artery territory.</pubmed_title><pmcid>PMC12284089</pmcid><funding_grant_id>U24 NS113844</funding_grant_id><funding_grant_id>R21 NR020231</funding_grant_id><funding_grant_id>U54 GM104942</funding_grant_id><funding_grant_id>R21 NS131756</funding_grant_id><pubmed_authors>Mendes Pereira V</pubmed_authors><pubmed_authors>Pedicelli A</pubmed_authors><pubmed_authors>Filipe JP</pubmed_authors><pubmed_authors>Gonzalez N</pubmed_authors><pubmed_authors>Mohlenbruch MA</pubmed_authors><pubmed_authors>Daraghma M</pubmed_authors><pubmed_authors>Barreau X</pubmed_authors><pubmed_authors>Yedavalli V</pubmed_authors><pubmed_authors>Fahed R</pubmed_authors><pubmed_authors>Quintero-Consuegra M</pubmed_authors><pubmed_authors>Spears J</pubmed_authors><pubmed_authors>Faizy TD</pubmed_authors><pubmed_authors>Shaikh H</pubmed_authors><pubmed_authors>Biswas A</pubmed_authors><pubmed_authors>Salazar-Marioni S</pubmed_authors><pubmed_authors>Marnat G</pubmed_authors><pubmed_authors>Henninger N</pubmed_authors><pubmed_authors>Guenego A</pubmed_authors><pubmed_authors>Kuhn AL</pubmed_authors><pubmed_authors>Bellante F</pubmed_authors><pubmed_authors>Vagal A</pubmed_authors><pubmed_authors>Kalsoum E</pubmed_authors><pubmed_authors>Dmytriw AA</pubmed_authors><pubmed_authors>Colasurdo M</pubmed_authors><pubmed_authors>Abdalkader M</pubmed_authors><pubmed_authors>Heit JJ</pubmed_authors><pubmed_authors>Siegler JE</pubmed_authors><pubmed_authors>Cancelliere NM</pubmed_authors><pubmed_authors>Lakhani DA</pubmed_authors><pubmed_authors>Clarencon F</pubmed_authors><pubmed_authors>Renieri L</pubmed_authors><pubmed_authors>Yeo LL</pubmed_authors><pubmed_authors>Berge J</pubmed_authors><pubmed_authors>AliAziz-Sultan M</pubmed_authors><pubmed_authors>Klein P</pubmed_authors><pubmed_authors>Forestier G</pubmed_authors><pubmed_authors>Musmar B</pubmed_authors><pubmed_authors>Stapleton CJ</pubmed_authors><pubmed_authors>El Naamani K</pubmed_authors><pubmed_authors>Hecker C</pubmed_authors><pubmed_authors>Wintermark M</pubmed_authors><pubmed_authors>Fiehler J</pubmed_authors><pubmed_authors>Elhorany M</pubmed_authors><pubmed_authors>Schiphorst AT</pubmed_authors><pubmed_authors>Mph K</pubmed_authors><pubmed_authors>Griessenauer CJ</pubmed_authors><pubmed_authors>Dofuku S</pubmed_authors><pubmed_authors>Harker P</pubmed_authors><pubmed_authors>Premat K</pubmed_authors><pubmed_authors>Costalat V</pubmed_authors><pubmed_authors>Scarcia L</pubmed_authors><pubmed_authors>Capirossi C</pubmed_authors><pubmed_authors>Varela R</pubmed_authors><pubmed_authors>Baker A</pubmed_authors><pubmed_authors>Gopinathan A</pubmed_authors><pubmed_authors>Regenhardt RW</pubmed_authors><pubmed_authors>Kadirvel R</pubmed_authors><pubmed_authors>Liebeskind DS</pubmed_authors><pubmed_authors>Hsieh CY</pubmed_authors><pubmed_authors>Weyland C</pubmed_authors><pubmed_authors>Mounayer C</pubmed_authors><pubmed_authors>Essibayi MA</pubmed_authors><pubmed_authors>Martinez-Gutierrez JC</pubmed_authors><pubmed_authors>Sheth SA</pubmed_authors><pubmed_authors>Mowla A</pubmed_authors><pubmed_authors>Killer-Oberpfalzer M</pubmed_authors><pubmed_authors>Puri AS</pubmed_authors><pubmed_authors>Rabinov JD</pubmed_authors><pubmed_authors>Meyer L</pubmed_authors><pubmed_authors>Khalife J</pubmed_authors><pubmed_authors>MAD-MT Investigators</pubmed_authors><pubmed_authors>Altschul D</pubmed_authors><pubmed_authors>Tan BY</pubmed_authors><pubmed_authors>Stracke CP</pubmed_authors><pubmed_authors>Tancredi I</pubmed_authors><pubmed_authors>Amllay A</pubmed_authors><pubmed_authors>Ota T</pubmed_authors><pubmed_authors>Jesser J</pubmed_authors><pubmed_authors>Dyzmann C</pubmed_authors><pubmed_authors>PhD IS</pubmed_authors><pubmed_authors>Hugo H</pubmed_authors><pubmed_authors>Gory B</pubmed_authors><pubmed_authors>Lubicz B</pubmed_authors><pubmed_authors>Valente I</pubmed_authors><pubmed_authors>Jabbour P</pubmed_authors><pubmed_authors>Aziz Y</pubmed_authors><pubmed_authors>Khandelwal P</pubmed_authors><pubmed_authors>Radu RA</pubmed_authors><pubmed_authors>Adeeb N</pubmed_authors><pubmed_authors>Patel AB</pubmed_authors><pubmed_authors>Nguyen TN</pubmed_authors><pubmed_authors>Nedelcu S</pubmed_authors><pubmed_authors>Tjoumakaris SI</pubmed_authors><pubmed_authors>Ghozy S</pubmed_authors><pubmed_authors>Thomas AJ</pubmed_authors><pubmed_authors>Sundararajan SH</pubmed_authors><pubmed_authors>Marotta TR</pubmed_authors><pubmed_authors>Dusart A</pubmed_authors><pubmed_authors>Salim HA</pubmed_authors><pubmed_authors>Chervak L</pubmed_authors><pubmed_authors>Saleme S</pubmed_authors><pubmed_authors>Alexandre AM</pubmed_authors><pubmed_authors>Rouchaud A</pubmed_authors><pubmed_authors>Peter T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical outcomes of patients with unsuccessful mechanical thrombectomy versus best medical management of medium vessel occlusion stroke in the middle cerebral artery territory.</name><description>&lt;h4>Background&lt;/h4>Current randomized controlled trials are investigating the efficacy and safety of mechanical thrombectomy (MT) in patients with medium vessel occlusion (MeVO) stroke. Whether best medical management (MM) is more efficient than unsuccessful vessel recanalization during MT remains unknown.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study using data from 37 academic centers across North America, Asia, and Europe between September 2017 and July 2021. Only patients with occlusion of the distal branches (M2 and M3) of the middle cerebral artery territory were included. Unsuccessful MT was defined as a modified Thrombolysis in Cerebral Infarction score of 0-2a. Propensity score matching was used to control for confounders. The primary outcome was functional independence, de</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-03-16T05:41:28.674Z</modification><creation>2025-08-14T03:06:22.143Z</creation></dates><accession>S-EPMC12284089</accession><cross_references><pubmed>39855674</pubmed><doi>10.1136/jnis-2024-022642</doi></cross_references></HashMap>